SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anlon Healthcare - Quaterly Results

12 Nov 2025 Evaluate
An increase of about 116.01% to Rs. 522.01 millions in the total revenue was observed for the quarter ended September 2025. The total revenue was pegged at Rs. 241.66 millions during the similar quarter previous year.The Net Profit of the company vaulted to 259.45% to Rs. 93.17  millions from Rs. 25.92 millions in the previous quarter.OP of the company witnessed a marginal growth to 137.65 millions from 75.68 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202509 202409 % Var
Sales 522.01 241.66 116.01 522.01 241.66 116.01 522.01 241.66 116.01
Other Income 0.27 0.46 -41.30 0.27 0.46 -41.30 0.27 0.46 -41.30
PBIDT 137.65 75.68 81.88 137.65 75.68 81.88 137.65 75.68 81.88
Interest 8.66 9.30 -6.88 8.66 9.30 -6.88 8.66 9.30 -6.88
PBDT 128.99 66.38 94.32 128.99 66.38 94.32 128.99 66.38 94.32
Depreciation 4.52 4.73 -4.44 4.52 4.73 -4.44 4.52 4.73 -4.44
PBT 124.47 61.65 101.90 124.47 61.65 101.90 124.47 61.65 101.90
TAX 31.30 35.73 -12.40 31.30 35.73 -12.40 31.30 35.73 -12.40
Deferred Tax -0.29 -0.20 45.00 -0.29 -0.20 45.00 -0.29 -0.20 45.00
PAT 93.17 25.92 259.45 93.17 25.92 259.45 93.17 25.92 259.45
Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDTM(%) 26.37 31.32 -15.80 26.37 31.32 -15.80 26.37 31.32 -15.80

Anlon Healthcare Share Price

13.09 -0.21 (-1.58%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.10
Dr. Reddys Lab 1287.95
Cipla 1334.85
Zydus Lifesciences 901.65
Lupin 2350.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×